• OrthoTrophix Presents Evidence for Disease Modification in Knee Osteoarthritis by TPX-100 at …

    OAKLAND, Calif.–(BUSINESS WIRE)–. OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that TPX-100 treatment is …

    Read More
  • 0 0